Where does CAS Center FOR Excellence IN Molecular Plant Sciences rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CAS Center FOR Excellence IN Molecular Plant Sciences ranks #34,672 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is CAS Center FOR Excellence IN Molecular Plant Sciences's Innovation Score?

CAS Center FOR Excellence IN Molecular Plant Sciences has an Innovation Score of 30.6 out of 100 (35th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is CAS Center FOR Excellence IN Molecular Plant Sciences's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for CAS Center FOR Excellence IN Molecular Plant Sciences.

What does claim depth mean for CAS Center FOR Excellence IN Molecular Plant Sciences's patents?

CAS Center FOR Excellence IN Molecular Plant Sciences's patents average 6.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CAS Center FOR Excellence IN Molecular Plant Sciences

Q: How many patents does CAS Center FOR Excellence IN Molecular Plant Sciences hold?

CAS Center FOR Excellence IN Molecular Plant Sciences holds 7 US utility patents granted between 2020 and 2025, spanning 13 technology areas.

Q: What technology areas does CAS Center FOR Excellence IN Molecular Plant Sciences focus on?

CAS Center FOR Excellence IN Molecular Plant Sciences's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents, ranking #1,801 of 4,144 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Q: How is the CAS Center FOR Excellence IN Molecular Plant Sciences patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, CAS ranks #34,672 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 13 technology areas.

#34,672
of 49,997 US assignees by volume: 35th percentile
by Innovation Score (30.6/100): 6.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34672 · Foreign Corporation #34,672 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #34,672/49,997
PHOTO-FINISH Cardix Therapeutics
CPC-FOCUS C12N · 13 areas
INNOV-THIN 30.6/100
CLAIMS-SPARSE 6.7 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cardix Therapeutics, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CAS’s 30.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (24%) Velocity 6.7 pts (22%) Breadth 12.7 pts (42%) Claim depth 4.0 pts (13%)

Qualcomm Incorporated · highest

85
CAS Center FOR… · this assignee

31
3D Lighting… · lowest

7

What this shows CAS's Innovation Score is 30.6/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for CAS?

Each dot is one of CAS’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CAS’s own 6.7 claims/patent is at or below the 19.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

CAS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CAS's grants concentrate

CAS Center FOR Excellence IN Molecular Plant Sciences is a focused PatentsView assignee: 13 CPC subclasses with 71.4% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2020. By volume, CAS sits between Cardix Therapeutics, LLC and Catarc New Energy Vehicle Test Center (Tianjin) Co., Ltd..

CAS's three-year grant acceleration

CAS Center FOR Excellence IN Molecular Plant Sciences shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cardix Therapeuti…

7
Cardlytics

7
Carnot Compression

7
Carolina Coupon C…

7
Casco Products

7
Castle Creations

7
Castle Hill Holdi…

7
Catarc New Energy…

7
CAS Center FOR Ex… ◀

7

What this shows CAS holds 7 patents at rank #34,641, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CAS

By rank, the assignees closest to #34,641 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in CAS's primary technology class.

CAS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

CAS Center FOR Excellence IN Molecular Plant Sciences patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	14.3%
2021	2	28.6%
2023	2	28.6%
2024	1	14.3%
2025partial year	1	14.3%

Which technologies does CAS Center FOR Excellence IN Molecular Plant Sciences patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C12Y - Enzymes 2

C07D - Heterocyclic Compounds 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

A01P - Biocidal, Pest Repellant, Pest Attractant OR Plant Growth Regulatory Activity OF Chemical Compounds OR Preparations 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07K - Peptides 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CAS Center FOR Excellence IN Molecular Plant Sciences's patent record in context - here's where to go next.

CAS Center FOR Excellence IN Molecular Plant Sciences's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 71.4% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #34,672 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CAS Center FOR Excellence IN Molecular Plant Sciences against Cardix Therapeutics, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.